BeOne Medicines (BEIGF) Share-based Compensation Growth (1y) (2016 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) Share-based Compensation Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | -119.48% |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | -7.26% |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | 37.96% |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 22.66% |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 4.11% |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | -49.74% |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | -8.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.89% |
| Mar 31, 2026 | 29.20% |
| Dec 31, 2025 | 15.00% |
| Sep 30, 2025 | 22.77% |
| Jun 30, 2025 | 15.44% |
| Mar 31, 2025 | 7.68% |
| Dec 31, 2024 | 15.82% |
| Sep 30, 2024 | 19.47% |
| Jun 30, 2024 | 26.38% |
| Mar 31, 2024 | 17.72% |
| Dec 31, 2023 | 18.94% |
| Sep 30, 2023 | 22.80% |
| Jun 30, 2023 | 27.14% |
| Mar 31, 2023 | 14.90% |
| Dec 31, 2022 | 23.99% |
| Sep 30, 2022 | 16.55% |
| Jun 30, 2022 | 25.49% |
| Mar 31, 2022 | 43.03% |
| Dec 31, 2021 | 27.40% |
| Sep 30, 2021 | 33.36% |